Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of BRD1 mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRD1 mRNA | decreases expression | 19150397
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of BRD1 mRNA | increases expression | 20106945
|
C406082 |
monomethylarsonous acid |
[monomethylarsonous acid affects the acetylation of HIST3H3 protein] which affects the methylation of BRD1 promoter | affects acetylation|affects methylation | 18448484
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of BRD1 mRNA | increases expression | 17560707
|
D012402 |
Rotenone |
Rotenone results in decreased expression of BRD1 mRNA | decreases expression | 19013527
|
C017947 |
sodium arsenite |
[sodium arsenite affects the acetylation of HIST3H3 protein] which affects the methylation of BRD1 promoter | affects acetylation|affects methylation | 18448484
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.34 | 7525203 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.14 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.35 | 16712894 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.00 | 15276417 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.44 | 18572023 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.78 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
17.63 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.63 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
17.63 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
17.63 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.12 | 19486331 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.41 | 15095906 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
2.69 | 21346803 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
3.86 | 17259670 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.14 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.50 | 12168785 12639820 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.08 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.62 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.82 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
4.45 | 3609246 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.40 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.07 | 12083418 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.18 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.16 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
3.18 | 12083418 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.88 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.50 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.50 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.97 | 12371664 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.63 | 8812269 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
5.19 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
5.19 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.35 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.89 | 17306315 17077188 16712894 19931552 15276417 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.06 | 16487513 19082730 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.23 | 16801185 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.61 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.02 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.88 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.53 | 19348381 18481113 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
4.09 | 15790535 18619942 17356569 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.31 | 12854658 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.31 | 9802331 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.36 | 14694615 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.50 | 15276417 17306315 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.06 | 19232380 16412576 18619942 15451049 19114014 16140633 11535288 18191903 11445065 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.34 | 15574749 15795934 15927086 18197244 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.47 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
4.79 | 17132714 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.25 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.43 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.81 | 19524636 18572023 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.01 | 12854658 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
5.83 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.83 | 17306315 16712894 16452187 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.03 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.43 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.82 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.88 | 17120751 |